Distinct roles of ligand affinity and cytoskeletal anchorage in αIIbβ3 (GP IIb/IIIa)-mediated cell aggregation and adhesion

Platelets

Volumn 15, Issue 7, 2004, Pages 427-438

  Peter, Karlheinz ^a   Ahrens, Ingo ^a   Schwarz, Meike ^a   Bode, Christoph ^a   Ylänne, Jari ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; AMINO ACID; FIBRINOGEN RECEPTOR; GLYCINE; INTEGRIN ALPHAIIB BETA3; LYSINE; PHENYLALANINE; UNCLASSIFIED DRUG; VALINE;

ALPHA CHAIN; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BETA CHAIN; BINDING AFFINITY; CHO CELL; CYTOPLASM; CYTOSKELETON; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

ANIMALS; CELL AGGREGATION; CHO CELLS; CRICETINAE; CYTOSKELETON; HUMANS; LIGANDS; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SEQUENCE DELETION;

ANIMALIA;

EID: 8744245429     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09587100410001723179     Document Type: Article

References (47)

1. Ruggeri Z M. Platelets in atherothrombosis. Nat Med 2002; 8: 1227-34.
2. Hynes R O. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110: 673-87.
3. Peter K, O'Toole T E. Modulation of cell adhesion by changes in alpha L beta 2 (LFA-1, CD11a/CD18) cytoplasmic domain/cytoskeleton interaction. J Exp Med 1995; 181: 315-26.
4. Ylanne J, Huuskonen J, O'Toole T E, Ginsberg M H, Virtanen I, Gahmberg C G. Mutation of the cytoplasmic domain of the integrin beta 3 subunit. Differential effects on cell spreading, recruitment to adhesion plaques, endocytosis, and phagocytosis. J Biol Chem 1995; 270: 9550-7.
5. Takagi J, Petre B M, Walz T, Springer T A. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 2002; 110: 599-11.
6. Shattil S J. Signaling through platelet integrin alpha IIb beta 3: inside-out, outside-in, and sideways. Thromb Haemost 1999; 82: 318-25.
7. Ylanne J, Hormia M, Jarvinen M, Vartio T, Virtanen I. Platelet glycoprotein IIb/IIIa complex in cultured cells. Localization in focal adhesion sites in spreading HEL cells. Blood 1988; 72: 1478-86.
8. O'Toole T E, Katagiri Y, Faull R J, Peter K, et al. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 1994; 124: 1047-59.
9. Wagner C L, Mascelli M A, Neblock D S, Weisman H F, Coller B S, Jordan R E. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 1996; 88: 907-14.
10. Arnaout M A, Goodman S L, Xiong J P. Coming to grips with integrin binding to ligands. Curr Opin Cell Biol 2002; 14: 641-51.
11. Du X P, Plow E F, Frelinger A L, 3rd, O'Toole T E, Loftus J C, Ginsberg M H. Ligands 'activate' integrin alpha IIb beta 3 (platelet GPIIb-IIIa). Cell 1991; 65: 409-16.
12. Peter K, Schwarz M, Ylanne J, et al. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors. Blood 1998; 92: 3240-9.
13. Kouns W C, Fox C F, Lamoreaux W J, Coons L B, Jennings L K. The effect of glycoprotein IIb-IIIa receptor occupancy on the cytoskeleton of resting and activated platelets. J Biol Chem 1991; 266: 13891-900.
14. Fox J E, Shattil S J, Kinlough-Rathbone R L, Richardson M, Packham M A, Sanan D A. The platelet cytoskeleton stabilizes the interaction between alphaIIbbeta3 and its ligand and induces selective movements of ligand-occupied integrin. J Biol Chem 1996; 271: 7004-11.
15. Tadokoro S, Shattil S J, Eto K, et al. Talin binding to integrin beta tails: a final common step in integrin activation. Science 2003; 302: 103-6.
16. Ylanne J, Chen Y, O'Toole T E, Loftus J C, Takada Y, Ginsberg M H. Distinct functions of integrin alpha and beta subunit cytoplasmic domains in cell spreading and formation of focal adhesions. J Cell Biol 1993; 122: 223-33.
17. Wang N, Butler J P, Ingber D E. Mechanotransduction across the cell surface and through the cytoskeleton. Science 1993; 260: 1124-7.
18. Geiger B, Bershadsky A, Pankov R, Yamada K M. Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2001; 2: 793-805.
19. Calderwood D A, Ginsberg M H. Talin forges the links between integrins and actin. Nat Cell Biol 2003; 5: 694-7.
20. Boudignon-Proudhon C, Patel P M, Parise L V. Phorbol ester enhances integrin alpha IIb beta 3-dependent adhesion of human erythroleukemic cells to activation-dependent monoclonal antibodies. Blood 1996; 87: 968-76.
21. Ylanne J, Cheresh D A, Virtanen I. Localization of beta 1, beta 3, alpha 5, alpha v, and alpha IIb subunits of the integrin family in spreading human erythroleukemia cells. Blood 1990; 76: 570-7.
22. Olorundare O E, Simmons S R, Albrecht R M. Cytochalasin D and E: effects on fibrinogen receptor movement and cytoskeletal reorganization in fully spread, surface-activated platelets: a correlative light and electron microscopic investigation. Blood 1992; 79: 99-109.
23. Addo J B, Bray P F, Grigoryev D, Faraday N, Goldschmidt-Clermont P J. Surface recruitment but not activation of integrin alpha IIb beta 3 (GPIIb-IIIa) requires a functional actin cytoskeleton. Arterioscler Thromb Vasc Biol 1995; 15: 1466-73.
24. Danilov Y N, Juliano R L. Phorbol ester modulation of integrin-mediated cell adhesion: a postreceptor event. J Cell Biol 1989; 108: 1925-33.
25. Faull R J, Kovach N L, Harlan J M, Ginsberg M H. Stimulation of integrin-mediated adhesion of T lymphocytes and monocytes: two mechanisms with divergent biological consequences. J Exp Med 1994; 179: 1307-16.
26. Lotz M M, Burdsal C A, Erickson H P, McClay D R. Cell adhesion to fibronectin and tenascin: quantitative measurements of initial binding and subsequent strengthening response. J Cell Biol 1989; 109: 1795-805.
27. Burn P, Kupfer A, Singer S J. Dynamic membrane-cytoskeletal interactions: specific association of integrin and talin arises in vivo after phorbol ester treatment of peripheral blood lymphocytes. Proc Natl Acad Sci USA 1988; 85: 497-501.
28. Kucik D F, Dustin M L, Miller J M, Brown E J. Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J Clin Invest 1996; 97: 2139-44.
29. O'Toole T E, Loftus J C, Du X P, et al. Affinity modulation of the alpha IIb beta 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor. Cell Regul 1990; 1: 883-93.
30. Tadokoro S, Shattil S J, Eto K, et al. Talin binding to integrin beta tails: A final common step in integrin activation. Science 2003; 302: 103-6.
31. Huttenlocher A, Ginsberg M H, Horwitz A F. Modulation of cell migration by integrin-mediated cytoskeletal linkages and ligand-binding affinity. J Cell Biol 1996; 134: 1551-62.
32. Wu C, Keivens V M, O'Toole T E, McDonald J A, Ginsberg M H. Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell 1995; 83: 715-24.
33. Chen Y P, O'Toole T E, Ylanne J, Rosa J P, Ginsberg M H. A point mutation in the integrin beta 3 cytoplasmic domain (S752→P) impairs bidirectional signaling through alpha IIb beta 3 (platelet glycoprotein IIb-IIIa). Blood 1994; 84: 1857-65.
34. Wang R, Shattil S J, Ambruso D R, Newman P J. Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex. J Clin Invest 1997; 100: 2393-403.
35. Nurden A T. Inherited abnormalities of platelets. Thromb Haemost 1999; 82: 468-80.
36. Hughes P E, O'Toole T E, Ylänne J, Shattil S J, Ginsberg M H. The conserved membrane-proximal region of an integrin cytoplasmic domain specifies ligand binding affinity. J Biol Chem 1995; 270: 12411-17.
37. Hughes P E, Diaz-Gonzalez F, Leong L, et al. Breaking the integrin hinge. J Biol Chem 1996; 271: 6571-4.
38. Nieswandt B, Watson S P. Platelet-collagen interaction: is GPVI the central receptor? Blood 2003; 102: 449-61.
39. Bombeli T, Schwartz B R, Harlan J M. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 1998; 187: 329-39.
40. Massberg S, Brand K, Grüner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002; 196: 887-96.
41. Gawaz M. Do platelets trigger atherosclerosis? Thromb Haemost 2003; 90: 971-2.
42. Quinn M J, Byzova T V, Qin J, Topol E J, Plow E F. Integrin αIIbβ3 and its antagonism. Arterioscler Thromb Vasc Biol 2003; 23: 945-52.
43. Bhatt D L, Topol E J. Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov 2003; 2: 15-28.
44. Shattil S J, Hoxie J A, Cunningham M, Brass L F. Changes in the platelet membrane glycoprotein Ub-IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107-14.
45. Dabadie M, Valli N, Jacobin M J, Laroche-Traineau J, Barat J L, Ducassou D, Nurden A T, Clofent-Sanchez G. Characterisation, cloning and sequencing of a conformation-dependent monoclonal antibody to the alphaIIbbeta3 integrin: interest for use in thrombus detection. Platelets 2001; 12: 395-405.
46. Jacobin M J, Laroche-Traineau J, Little M, Keller A, Peter K, Welschof M, Nurden A, Clofent-Sanchez G. Human IgG monoclonal anti-alpha(IIb)beta(3)- binding fragments derived from immunized donors using phage display. J Immunol 2002; 168: 2035-45.
47. Schwarz M, Roettgen P, Takada Y, Little M, Bode C, Peter K. Generation and affinity maturation of synthetic conformation-specific single-chain antibodies against GPIIb/IIIa for a new therapeutic anti-platelet strategy. Circulation 2003; 108: 1092.